IP Industry Roundup: Week of March 14, 2019

We’re back with your weekly IP roundup! We’ve collect some of the most interesting articles from this past week to share with you.

US Biotech Company Makes Claims Against Irish Rival

It seems California-based Genetech won’t be kissing it’s Irish rivals Amgen Incorprorated this St. Patrick’s Day. Genetech is seeking an injunction against Amgen, claiming they are producing a stockpile of their drug Mvasi in order to flood the US market. Mvasi is biosimilar to Genetech’s massively financially successful cancer treatment, Avastin, and, according to Genetech infringes upon their drug patent.

The People of India vs. Janssen

In India, survivors of tuberculosis are banding together to push against a patent application submitted by the pharmaceutical company Janssen (Johnson & Johnson). The patent would update the pre-existing drug bedelaquin, a drug that fights against multi-drug resistant tuberculosis and is considered an essential medicine throughout the developed world. By updating the drug, Janssen would be able to extend the patent and prevent the release of generic versions of bedelaquin.

In India, where multi-drug resistant tuberculosis is considered a major disease, the release of a generic medicine could help save lives. According to the two survivors leading the campaign against the Janssen, the new application lacks any novelty and does not warrant a new patent that would extend the patent and prevent the drug from getting into the hands of those who need it.

Video Gaming with Google Assistant

The video game industry has been all abuzz lately with rumors technology titan Google might be throwing its hat into the ring with its own gaming system. Details have been sparse, most believe Google will be releasing a streaming service, while there is suspicion there could be an entire Google console.

A recent patent shows that Google is at least considering some hardware releases for their foray into the gaming industry. The patent is for a Google video game controller. The controller itself is quite standard, matching the controller layouts for Sony’s Playstation and Microsoft’s XBox. However, one feature stands out: in the middle of the controller is a button that could enable Google Assistant.

Missing a Deadline Leads to Failed Registration

One company learned this week that when given a deadline, it’s best to actually make sure its followed. Elanco, a pharmaceutical company, discovered that ministers in Canada have refused to list the patent for their drug Imprestor after the company missed their filing date and submitted administrative documents too late. The lesson is obvious; paperwork needs to be finished on time!

Celebrities Trademark Baby Names

Actress Gabrielle Union and husband, NBA player Dwayne Wade, successfully trademarked the name of their 4-month old daughter, Kaavia James, and her nickname ‘Shady Baby.’ The couple are establishing a company with a wide range of products trademarked under their baby’s name.

Celebrities attempting to trademark the names of their children has been an increasing trend, but more often than not the trademarks are rejected. Jay-Z and Beyonce have been in the news with their failed attempts to trademark their daughter Blue Ivy’s name, while the Kardashians have a whole slew of names they’d like to trademark. While it may seem funny, the hype surrounding the birth of celebrity children can lead to people profiting off their names, and it is only natural that these celebs would want to protect the identity of their babies.

By |2019-04-29T11:11:39+00:00March 14th, 2019|Blog|0 Comments